US Patent Issued to New York University on Feb. 24 for "Methods and compositions for treating 4-hydroxyphenylpyruvate dioxygenase-like (HPDL)-related diseases or disorders" (New York Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,329, issued on Feb. 24, was assigned to New York University (New York).

"Methods and compositions for treating 4-hydroxyphenylpyruvate dioxygenase-like (HPDL)-related diseases or disorders" was invented by Robert Banh (New York), Michael Pacold (New York), Quentin Spillier (New York) and Guangbin Shi (Mineola, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various methods and compositions of treating 4-hydroxyphenylpyruvate dioxygenase-like (HPDL)-related diseases or disorders are presented herein. Also presented herein are methods of increasing CoQ10 biosynthesis, and methods of determining whether a subject will benefit from a CoQ10 or CoQ10 ...